{"comparisonGroups":["Control_Oral_Blood","RESV_Oral_Blood"],"dateCreated":"2025-09-26 00:00:00","display_title":"Blood: oral RESV treatment vs control","group_a_title":"Control group for oral administration in blood samples. Provides baseline for comparison with RESV oral treatment in blood","group_b_title":"RESV treatment group for oral administration in blood samples. Evaluates the effect of RESV oral treatment in blood","id":"MTBLS125_0002_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS125","studyUrl":"http://integmet.org/study/MTBLS125","title":"Control_Oral_Blood_vs_RESV_Oral_Blood","topHits":[{"chebi_id":"43355","direction":"up","inn_name":"","iupac_name":"1<em>H</em>-indol-3-yl hydrogen sulfate","metabolite_id":"BXFFHSIDQOFMLE-UHFFFAOYSA-N","pvalue":0.039413681369028,"ratio":1.9745448730985715,"synonym_name":"3-indolyl sulfate"}],"totalFeatures":116}